Two-year results from a phase 2 extension study of oral amiselimod in relapsing multiple sclerosis

por Kappos, Ludwig, Arnold, Douglas L, Bar-Or, Amit, Camm, A John, Derfuss, Tobias, Sprenger, Till, Davies, Martin, Piotrowska, Alexandra, Ni, Pingping, Harada, Tomohiko
Publicado 2017